In vitroOATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia

Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver

(2012) Evita van de Steeg et al.   JOURNAL OF CLINICAL INVESTIGATION

Systemic Absorption of Rifamycin SV MMX Administered as Modified-Release Tablets in Healthy Volunteers

(2011) A. F. D. Di Stefano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects

(2010) Christina Fahrmayr et al.   DRUG METABOLISM REVIEWS

Incidence of Atazanavir-associated Hyperbilirubinemia in Korean HIV Patients: 30 Months Follow-up Results in a Population with Low UDP-glucuronosyltransferase1A1*28 Allele Frequency

(2010) Pyoeng Gyun Choe et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Membrane transporters in drug development

(2010)   NATURE REVIEWS DRUG DISCOVERY

Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1

(2010) P. Annaert et al.   XENOBIOTICA

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

(2009) A. Barrail-Tran et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genome-wide association meta-analysis for total serum bilirubin levels

(2009) A. D. Johnson et al.   HUMAN MOLECULAR GENETICS

Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia

(2009) Serena Sanna et al.   HUMAN MOLECULAR GENETICS

Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts

(2009) C. Torti et al.   INFECTION

Gilbert’s syndrome and hyperbilirubinemia in protease inhibitor therapy – An extended haplotype of genetic variants increases risk in indinavir treatment

(2009) Tim O. Lankisch et al.   JOURNAL OF HEPATOLOGY

Complex Multifactorial Nature of Significant Hyperbilirubinemia in Neonates

(2009) J. F. Watchko et al.   PEDIATRICS

Hepatic Nuclear Factor 1  Inhibitor Ursodeoxycholic Acid Influences Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 Substrate Rosuvastatin and Bilirubin

(2008) Y.-J. He et al.   DRUG METABOLISM AND DISPOSITION

Drug-induced Hyperbilirubinemia and the Clinical Influencing Factors

(2008) Young-Mi Ah et al.   DRUG METABOLISM REVIEWS

Coexpression of Gene Polymorphisms Involved in Bilirubin Production and Metabolism

(2008) Z. Lin et al.   PEDIATRICS